Sexually Transmitted Infections (STIs)

Active Projects: 94

Project Investigator
 		All Topics Start date End date
Intervention to Decrease Risk for STDs and Unintended Pregnancies in Active Duty Military Women Sexually Transmitted Infections (STIs), Women's Health, Family Planning
A New Field Assay to Diagnose and Monitor Schistosomiasis Sexually Transmitted Infections (STIs), Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development
Multidrug-Resistant CA-MRSA Infections Among HIV+ Persons: CA AIDS Grant ID07-REI-129 Henry Chambers, MD Infectious Disease, Sexually Transmitted Infections (STIs), Zoonosis, Emerging Disease, and Drug Resistance, HIV/AIDS, Epidemiology and Surveillance
UZ-UCSF Clinical Trials Unit Zvavahera Chirenje, MD, FRCOG Sexually Transmitted Infections (STIs), HIV/AIDS, Women's Health
University of California Global Health Institute Program for Fellows and Scholars Craig Cohen, MD, MPH Sexually Transmitted Infections (STIs), Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), HIV/AIDS, Opportunistic Infection, Tuberculosis, Malaria, Noncommunicable and/or Chronic Disease, Surgery and Anesthesia, Cancer/Oncology, Cardiovascular Disease, Chronic Respiratory Disease, Diabetes, Occupational and Environmental Disease, Diet, Exercise, and Obesity, Malnutrition, Micronutrients, Food Insecurity, Eye Disease and Blindness, Oral Health, Drug and Diagnostics Development, Immunology, Genetics, Pharmacology and Drug Treatment, Neurology and Mental Health, Dementia and Cognitive Impairment, Trauma and PTSD, Women's Health, Aging, Labor and Delivery, Family Planning, Pediatrics, Newborn and Infant Health, Adolescent Health, Health Economics and Effectiveness, Access or Barriers to Care, Immigration and Migration, Stigma and Discrimination, Smoking and Tobacco, Policy and Standards of Care, Systematic Reviews and Guideline Development, Epidemiology and Surveillance, Triangulation, Global Strategic Information, Implementation and Behavioral Science, Engagement in Care, Substance Abuse, Treatment Adherence, Health Systems Strengthening, Risk Reduction and Prevention, Residencies, Fellowships, and Postdoctoral Training
Satellite Symposium at Microbicides 2010 on Bacterial Therapeutics Craig Cohen, MD, MPH Sexually Transmitted Infections (STIs), HIV/AIDS, Women's Health
Mycoplasma Genitalium in the Female Genital Tract Craig Cohen, MD, MPH Infectious Disease, Sexually Transmitted Infections (STIs), Women's Health
Phase II-b Randomized Double-Blind Placebo-Controlled Trial of Lactobacillus Crispatus CTV-05 Craig Cohen, MD, MPH Sexually Transmitted Infections (STIs), Women's Health
Phase 2 placebo-controlled randomized trial of LACTIN-V (Lactobacillus crispatus CTV-05) among women at high risk of HIV acquisition in Durban, South Africa Craig Cohen, MD, MPH HIV/AIDS, Sexually Transmitted Infections (STIs), Women's Health
Preclinical Development of MucoCept Craig Cohen, MD, MPH Sexually Transmitted Infections (STIs), Women's Health
FACES Patient Care fund for research at Kenya Craig Cohen, MD, MPH HIV/AIDS, Infectious Disease, Sexually Transmitted Infections (STIs), Cancer/Oncology, Diet, Exercise, and Obesity, Women's Health, Labor and Delivery, Family Planning, Pediatrics, Newborn and Infant Health, Adolescent Health, Health Economics and Effectiveness, Access or Barriers to Care, Stigma and Discrimination, Training and Capacity Building, Training International Scholars and Clinicians
Chlamydia and Gonococcal Infection: Immunobiology in the Female Reproductive Tract Craig Cohen, MD, MPH Infectious Disease, Sexually Transmitted Infections (STIs), Women's Health
Investigation of the Natural History of Human Papillomavirus (HPV) DNA and Cervical Neoplasia in a Cohort of Sex Workers in Kenya Craig Cohen, MD, MPH Infectious Disease, Sexually Transmitted Infections (STIs), Women's Health
Novel approaches to identify host genes required for Chlamydia pathogenesis Joanne Engel, MD, PhD Infectious Disease, Sexually Transmitted Infections (STIs), Drug and Diagnostics Development
High throughput proteomics to dissect Chlamydia-host cell interactions Joanne Engel, MD, PhD Infectious Disease, Sexually Transmitted Infections (STIs), Genetics, Risk Reduction and Prevention
AIDS Education and Training Center, National Clinician Consultation Center Ronald Goldschmidt, MD Infectious Disease, Sexually Transmitted Infections (STIs), HIV/AIDS, Training International Scholars and Clinicians, Residencies, Fellowships, and Postdoctoral Training, UCSF Professional Education, Patient and Peer Education
Dynamic Modeling of the Hepatitis C Epidemic in Injection Drug Users Judith Hahn, PhD, MD Sexually Transmitted Infections (STIs), Epidemiology and Surveillance
HBV/HIV Co-Infection Research Network Mandana Khalili, MD Sexually Transmitted Infections (STIs), HIV/AIDS
Pegylated Interferon Lambda w/wo Daclatasvir, Compared to Pegylated Interferon Alfa, Plus Ribavirin in Subjects With Hepatitis C Genotype 2 and 3 Mandana Khalili, MD Sexually Transmitted Infections (STIs)
Mentoring Multidisciplinary Patient-Oriented Research in Viral Hepatitis Mandana Khalili, MD Sexually Transmitted Infections (STIs)
Insulin Resistance in HCV Infection Mandana Khalili, MD Sexually Transmitted Infections (STIs)
Registry for Subjects Who Achieve a Sustained Virologic Response to Treatment in Subjects with Chronic Hepatitis C Anne Luetkemeyer, MD Sexually Transmitted Infections (STIs)
Evaluation of doxycycline post-exposure prophylaxis to reduce sexually transmitted infections in PrEP users and HIV-infected men who have sex with men Anne Luetkemeyer, MD Sexually Transmitted Infections (STIs), Zoonosis, Emerging Disease, and Drug Resistance
A Phase 2, Open-Label Study of Daclatasvir (BMS-790052) and TMC435 in Combination With or Without Ribavirin (RBV) For Treatment-Naive Subjects or Null Responders to Prior Peginterferon Alfa (PegIFN)/RBV Therapy with Genotype 1 Chronic Hepatitis C Anne Luetkemeyer, MD Sexually Transmitted Infections (STIs)
A Phase 3, Open-label Study to Investigate the Efficacy and Safety of GS-7977 plus Ribavirin for 12 Weeks in Chronic Genotype 2 and 3 Hepatitis C Virus (HCV) Coinfected Subjects (GS-US-334-0123) Anne Luetkemeyer, MD Sexually Transmitted Infections (STIs)
Registry for Subjects Who Achieve a Sustained Virologic Response to Treatment in Subjects with Chronic Hepatitis C Anne Luetkemeyer, MD Sexually Transmitted Infections (STIs)
Bay Area Hepatitis C Cooperative Research Center Mike McCune, MD, PhD Infectious Disease, Sexually Transmitted Infections (STIs)
HCV Prevention and Care Education Kimberly Page, PhD, MPH Infectious Disease, Sexually Transmitted Infections (STIs), Patient and Peer Education
HCV Infection and Treatment in Parolees: Feasibility Study Kimberly Page, PhD, MPH Sexually Transmitted Infections (STIs)
Acute Hepatitis C Infection in Young Injectors Kimberly Page, PhD, MPH Sexually Transmitted Infections (STIs)
Hepatitis C: Studies of Immunity and Pathogenesis Kimberly Page, PhD, MPH Sexually Transmitted Infections (STIs)
APTIMA HPV Clinical Study on Anal Specimens from Men Who Have Sex with Men (MSM) Joel Palefsky, MD Sexually Transmitted Infections (STIs)
Next Generation of HPV and Cervical Cancer Research in HIV+ Women Joel Palefsky, MD HIV/AIDS, Infectious Disease, Sexually Transmitted Infections (STIs), Cancer/Oncology
AMC-103: A Phase 2 Evaluation of VGX-3100, a Synthetic DNA Immunotherapy Targeting Human Papillomavirus 16 and 18 E6 and E7 Proteins, for Anal High-Grade Squamous Intraepithelial Lesions (HSIL) in HIV-Positive Individuals Joel Palefsky, MD Infectious Disease, Sexually Transmitted Infections (STIs)
Thai Red Cross S&S, HPV TA008 Joel Palefsky, MD Infectious Disease, Sexually Transmitted Infections (STIs), Cancer/Oncology, Pharmacology and Drug Treatment
Thai Red Cross S&S, HN177 Joel Palefsky, MD Infectious Disease, Sexually Transmitted Infections (STIs), Cancer/Oncology
(PQ5) Role of HIV-associated cellular miRNAs in HPV 16-induced pathogenesis Joel Palefsky, MD Infectious Disease, Sexually Transmitted Infections (STIs), Cancer/Oncology
HPV Cervical Neoplasia in a Long-Term HIV+ Cohort Joel Palefsky, MD Sexually Transmitted Infections (STIs), Cancer/Oncology, Women's Health
GINI: Gardasil Immunogenicity with Needle-free Injection-Safety and Immunogenicity of Gardasil using IM and ID needle-free injection delivery Joel Palefsky, MD Sexually Transmitted Infections (STIs), Cancer/Oncology
Impact of HIV PMTCT Interventions on HBV Disease in n HIV/HBV Co-infected Women and their Infants Marion Peters, MD Sexually Transmitted Infections (STIs), HIV/AIDS, Women's Health
State Sexually Transmitted Disease Collaborative Program George Rutherford, MD Sexually Transmitted Infections (STIs), Epidemiology and Surveillance, Risk Reduction and Prevention
STD Prevention Training Center George Rutherford, MD Sexually Transmitted Infections (STIs), Residencies, Fellowships, and Postdoctoral Training, UCSF Professional Education
Support for Male Circumcision Evaluatation Meeting George Rutherford, MD Sexually Transmitted Infections (STIs), HIV/AIDS, Risk Reduction and Prevention
STD and Viral Hepatitis Prevention and Control George Rutherford, MD Infectious Disease, Sexually Transmitted Infections (STIs)
Sexually Transmitted Disease Prevention Projects: Implementation George Rutherford, MD Sexually Transmitted Infections (STIs), Epidemiology and Surveillance, Risk Reduction and Prevention
State Sexually Transmitted Disease Collaborative Program George Rutherford, MD Sexually Transmitted Infections (STIs)
A smartphone-based point-of-care test for detection of Chlamydia trachomatis Julius Schachter, PhD Sexually Transmitted Infections (STIs), Drug and Diagnostics Development
Evaluation of Abbott RealTime CT/NG for the Detection of C. trachomatis & N. gonorrhoeae from the Pharynx, Rectum & Urethra of MSM Julius Schachter, PhD Sexually Transmitted Infections (STIs)
Retrovirus Epidemiology Donor Study-II (REDS-II) Central Laboratory Mark Seielstad, PhD Infectious Disease, Sexually Transmitted Infections (STIs), Transfusion Medicine, Health Systems Strengthening
In Vivo Drug Interaction Study Sexually Transmitted Infections (STIs), Family Planning
Content from UCSF Physicians for SexReally.com J. Joseph Speidel, MD, MPH Sexually Transmitted Infections (STIs), HIV/AIDS, Women's Health, Family Planning, Adolescent Health, Patient and Peer Education
Role of HIV in acceleration of HPV malignancy Sharof Tugizov, PhD HIV/AIDS, Sexually Transmitted Infections (STIs), Cancer/Oncology
Microbicide Pregnancy Registry-Microbicide Trials Network Juan Vargas, MD Sexually Transmitted Infections (STIs), HIV/AIDS, Drug and Diagnostics Development, Women's Health
Microbicide Pregnancy Registry--Microbicide Trials Network Juan Vargas, MD Sexually Transmitted Infections (STIs), HIV/AIDS, Drug and Diagnostics Development, Women's Health, Family Planning
Microbicide Pregnancy Registry--Microbicide Trials Network Juan Vargas, MD Sexually Transmitted Infections (STIs), Drug and Diagnostics Development, Women's Health, Family Planning
Purine Metabolism in Trichomonas Vaginalis Infectious Disease, Sexually Transmitted Infections (STIs)
Identifying Community Factors Impacting STIs among Youth in California Claire Brindis, DrPH Sexually Transmitted Infections (STIs), Adolescent Health
Implementation science and reproductive health on sub-Saharan Africa Joelle Brown, PhD HIV/AIDS, Infectious Disease, Sexually Transmitted Infections (STIs), Women's Health, Labor and Delivery, Family Planning
Economic Opportunity for Zimbabwean Adolescent Orphans Philip Darney, MD, MS Sexually Transmitted Infections (STIs), HIV/AIDS
STI Screening as a Combined HIV Prevention Platform for MSM in Peru James Dilley, MD Sexually Transmitted Infections (STIs), HIV/AIDS, Epidemiology and Surveillance, Implementation and Behavioral Science, Engagement in Care
Sexually Transmitted Infections Clinical Trials Group (STICTG) Linda Giudice, MD, PhD, MSc Sexually Transmitted Infections (STIs)
Hepatitis C Co-infection Clinic: A to T (Acute to Transplant) Sexually Transmitted Infections (STIs), HIV/AIDS
VX11-950-115 An Open Label, Phase 3 Study of Telaprevir in Combination With Peginterferon Alfa 2a (Pegasys®) and Ribavirin (Copegus®) in Subjects Coinfected With Genotype 1 Hepatitis C Virus and Human Immunodeficiency Virus Type 1(HCV/HIV-1) Sexually Transmitted Infections (STIs), HIV/AIDS
Treatment of Acute Hepatitis C Virus in HIV Co-Infection Sexually Transmitted Infections (STIs), HIV/AIDS
Providers' Perceptions of the Diaphragm in Southern Africa and the United States Cynthia Harper, PhD Sexually Transmitted Infections (STIs), HIV/AIDS, Women's Health, Training International Scholars and Clinicians, UCSF Professional Education
HSV-2 Avidity Testing for Intervention for Male Sexually-Transmitted Disease (STD) Patients in India Christina (Krysia) Lindan, MD, MSc Sexually Transmitted Infections (STIs), HIV/AIDS
An Intervention for Male STD Patients in India / HIV Related Christina (Krysia) Lindan, MD, MSc Sexually Transmitted Infections (STIs), HIV/AIDS
Reducing Health Disparities in Unintended Pregnancies Among Hispanic Adolescents Using a Patient-Centered Computer-Based Clinic Intervention Sexually Transmitted Infections (STIs), Family Planning, Adolescent Health
Randomized Controlled Trial of 6% Cellulose Sulfate Gel and the Effect on Vaginal HIV Transmission Ariane Van der Straten, PhD, MPH Sexually Transmitted Infections (STIs), HIV/AIDS, Pharmacology and Drug Treatment
Congenital Syphilis Elimination Cost-Effectiveness Analysis James Kahn, MD, MPH Sexually Transmitted Infections (STIs), Health Economics and Effectiveness
A cognitive behavioral and structural HIV prevention intervention for young Ugandan women engaging in high risk sexual behavior Rachel King, PhD, MPH Sexually Transmitted Infections (STIs), HIV/AIDS, Women's Health, Implementation and Behavioral Science, Risk Reduction and Prevention
Improving Uses of New and Existing Technologies to Reduce Non-viral STIs in Developing Countries Sexually Transmitted Infections (STIs)
A Phase I Safety Trial of the Diaphragm in Zimbabwe Sexually Transmitted Infections (STIs), HIV/AIDS, Women's Health, Family Planning
Acceptability of Diaphragm Use to Prevent STDs/HIV Sexually Transmitted Infections (STIs), Women's Health
STD Risks and Latino Adolescents' Sexual Networks Sexually Transmitted Infections (STIs), Adolescent Health
HIV Risk Reduction Through HSV-2 Prevention with N-9 Sexually Transmitted Infections (STIs)
Acceptability of Barrier Methods for Disease Prevention Sexually Transmitted Infections (STIs)
San Francisco STDs CRC Sexually Transmitted Infections (STIs), Adolescent Health
Nanotextured Condoms: Surface Engineering for Better Safe Sex Sexually Transmitted Infections (STIs)
Understanding the Interpersonal Context of HIV/HCV risk within Injecting Dyads Meghan Morris, PhD, MPH Infectious Disease, Sexually Transmitted Infections (STIs), HIV/AIDS, Cancer/Oncology
Informing hepatitis C virus elimination strategies with epidemiological data from highest need populations Meghan Morris, PhD, MPH Infectious Disease, Sexually Transmitted Infections (STIs), Epidemiology and Surveillance
The No One Waits (NOW) Study: Acceptability, feasibility, and effectiveness of a community based on-site point-of-diagnosis HCV treatment study Meghan Morris, PhD, MPH Infectious Disease, Sexually Transmitted Infections (STIs), Pharmacology and Drug Treatment, Epidemiology and Surveillance
End HepC SF research to inform elimination Meghan Morris, PhD, MPH Infectious Disease, Sexually Transmitted Infections (STIs)
Cambodia Integrated HIV and Drug Prevention Implementation Ellen Stein, MPH Sexually Transmitted Infections (STIs), HIV/AIDS, Women's Health, Implementation and Behavioral Science, Engagement in Care, Treatment Adherence
Improving care delivery for people living with HIV, TB and other chronic diseases through diplomacy Michael J. Reid, MD Infectious Disease, Sexually Transmitted Infections (STIs), HIV/AIDS, Opportunistic Infection, Tuberculosis, Policy and Standards of Care, Systematic Reviews and Guideline Development, Health Systems Strengthening
Outreach-based STI and HIV testing for street youth in San Francisco Colette L. Auerswald, MD, MS Sexually Transmitted Infections (STIs), HIV/AIDS, Adolescent Health, Stigma and Discrimination, Risk Reduction and Prevention
Vulnerable youth, homelessness, and risk behaviors Colette L. Auerswald, MD, MS HIV/AIDS, Sexually Transmitted Infections (STIs), Access or Barriers to Care, Stigma and Discrimination
Global gene array, secretome analyses, and HIV infection analyses of foreskin epithelial cells upon exposure to cervicovaginal fluid from healthy vs. women with bacterial vaginosis Grace Turyasingura, MSc Sexually Transmitted Infections (STIs)
Identifying Opportunities to Increase Syphilis Partner Services Uptake and Improve Outcome Measures, San Francisco - Phase II Kim Koester, PhD Sexually Transmitted Infections (STIs), Engagement in Care
Expedited Partner Therapy and the HIV Prevention Cascade Among MSM in Peru Catherine Oldenburg, ScD, MPH Sexually Transmitted Infections (STIs)
Prevalence, incidence and risk factors for genital and rectal C. trachomatis and N. gonorrhoeae infections and antibiotic resistance in Fiji Deborah Dean, MD, MPH Sexually Transmitted Infections (STIs), Zoonosis, Emerging Disease, and Drug Resistance, Epidemiology and Surveillance
Chlamydial sexually transmitted diseases and trachoma Deborah Dean, MD, MPH Sexually Transmitted Infections (STIs), Zoonosis, Emerging Disease, and Drug Resistance, Eye Disease and Blindness, Drug and Diagnostics Development
Incidence, Prevalence and Risk Factors for Sexually Transmitted Infections in Fiji Deborah Dean, MD, MPH Infectious Disease, Sexually Transmitted Infections (STIs), Drug and Diagnostics Development
Prevalence of and Behaviors Associated with Chlamydia Trachomatis Sexually Transmitted Infections among Females in Suva, Fiji Ginny Svigals, MS Sexually Transmitted Infections (STIs)